🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective was to investigate the antiviral effect, safety, and pharmaco...
Status
Completed
Location
1220.5.0001 Boehringer Ingelheim Investigational Site
Start Date
2008-10
Trial ID
NCT00774397
This is a Phase 2, multi-center, randomized, open-label study to evaluate t...
Status
Completed
Location
Mayo Clinic
Start Date
2004-10
Trial ID
NCT00097435
Phase I trial to study the effectiveness of radiolabeled monoclonal antibod...
Status
Completed
Location
University of Alabama Comprehensive Cancer Center
Start Date
1996-03
Trial ID
NCT00002734
This multicenter, observational study will assess the efficacy and the safe...
Status
Completed
Location
Multiple Locations
Start Date
2014-11-24
Trial ID
NCT01679834
The purpose of this open-label study is to assess the safety, antiviral act...
Status
Unknown
Location
Fundacion de Investigation de Diego
Start Date
2012-11
Trial ID
NCT01727934
Treatments Being Tested
This is a non-randomized, open-label study examining the safety and efficac...
Status
Terminated
Location
University of Nebraska Medical Center
Start Date
2009-05-01
Trial ID
NCT00882193
Treatments Being Tested
This randomized phase III trial studies octreotide acetate and recombinant ...
Status
Active Not Recruiting
Location
Providence Hospital
Start Date
2007-12-01
Trial ID
NCT00569127
Treatments Being Tested
The purpose of this study is to determine if 48 weeks of therapy with Pegyl...
Status
Withdrawn
Location
Local Institution
Start Date
2012-03
Trial ID
NCT01447394
Treatments Being Tested
The purpose of this study is to assess the benefit of 177Lu-DOTATATE versus...
Status
Withdrawn
Location
Jules Bordet Institute
Start Date
2014-12
Trial ID
NCT01860742
Treatments Being Tested
The TORAVA trial is designed to evaluate the progression-free rate at 48 we...
Status
Completed
Location
Centre Paul Papin
Start Date
2008-02
Trial ID
NCT00619268
Treatments Being Tested